The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy
Abstract
Photodynamic therapy (PDT) has emerged as a promising clinical modality for cancer therapy due to its ability to initiate an antitumor immune response. However, PDT-mediated cancer immunotherapy is severely impaired by tumor-cell immunosuppression of host T cell antitumor activity through the programmed cell death 1 ligand (PD-L1) and programmed cell death receptor 1 (PD-1) (PD-L1-PD-1) immune checkpoint pathway. Here, we demonstrate that PDT-mediated cancer immunotherapy can be augmented by PD-L1 knockdown (KD) in tumor cells. We rationally designed a versatile micelleplex by integrating an acid-activatable cationic micelle, photosensitizer (PS), and small interfering RNA (siRNA). The micelleplex was inert at physiological pH conditions and activated only upon internalization in the acidic endocytic vesicles of tumor cells for fluorescence imaging and PDT. Compared to PDT alone, the combination of PDT and PD-L1 KD showed significantly enhanced efficacy for inhibiting tumor growth and distant metastasis in a B16-F10 melanoma xenograft tumor model. These results suggest that acid-activatable micelleplexes utilizing PDT-induced cancer immunotherapy are more effective when combined with siRNA-mediated PD-L1 blockade. This study could provide a general strategy for enhancing the therapy efficacy of photodynamic cancer therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Second window for in vivo imaging
Smith, A. M., Mancini, M. C., & Nie, S. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.326 · Cited by 2,848
Photodynamic therapy and anti-tumour immunity
Castano, A. P., Mroz, P., & Hamblin, M. R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1894 · Cited by 2,676
Zou, W., Wolchok, J. D., & Chen, L. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7118 · Cited by 2,400
Sensors and regulators of intracellular pH
Casey, J. R., Grinstein, S., & Orlowski, J. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2820 · Cited by 2,218
PD-L1 Expression in Triple-Negative Breast Cancer
Mittendorf, E. A., Philips, A. V., Meric-Bernstam, F., Qiao, N., Wu, Y., Harrington, S., Su, X., Wang, Y., Gonzalez-Angulo, A. M., Akcakanat, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0127 · Cited by 1,396
Lovell, J. F., Jin, C. S., Huynh, E., Jin, H., Kim, C., Rubinstein, J. L., Chan, W. C. W., Cao, W., Wang, L. V., & Zheng, G. (2011) · Nature Materials · doi:10.1038/nmat2986 · Cited by 1,362
Roles of heat-shock proteins in innate and adaptive immunity.
Srivastava, P. (2002) · Nature reviews. Immunology · doi:10.1038/nri749 · Cited by 1,069
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Enhanced Cancer Immunotherapy by Microneedle Patch-Assisted Delivery of Anti-PD1 Antibody
Wang, C., Ye, Y., Hochu, G. M., Sadeghifar, H., & Gu, Z. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b05030 · Cited by 784
Wang, Y., Zhou, K., Huang, G., Hensley, C., Huang, X., Ma, X., Zhao, T., Sumer, B. D., DeBerardinis, R. J., & Gao, J. (2014) · Nature Materials · doi:10.1038/nmat3819 · Cited by 773
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Cancer Immunotherapy by Dendritic Cells
Melief, C. J. M. (2008) · Immunity · doi:10.1016/j.immuni.2008.08.004 · Cited by 508
Chen, Q., Liang, C., Wang, C., & Liu, Z. (2015) · Advanced Materials · doi:10.1002/adma.201404308 · Cited by 453
Lynn, G. M., Laga, R., Darrah, P. A., Ishizuka, A. S., Balaci, A. J., Dulcey, A. E., Pechar, M., Pola, R., Gerner, M. Y., Yamamoto, A., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3371 · Cited by 440
Liu, Y., Liu, Y., Bu, W., Cheng, C., Zuo, C., Xiao, Q., Sun, Y., Ni, D., Zhang, C., Liu, J., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500478 · Cited by 425
Self-citationJin, C. S., Lovell, J. F., Chen, J., & Zheng, G. (2013) · ACS Nano · doi:10.1021/nn3058642 · Cited by 414
Engineering Nano‐ and Microparticles to Tune Immunity
Moon, J. J., Huang, B., & Irvine, D. J. (2012) · Advanced Materials · doi:10.1002/adma.201200446 · Cited by 404
Blocking of the PD‐1/PD‐L1 Interaction by a D‐Peptide Antagonist for Cancer Immunotherapy
Chang, H., Liu, B., Qi, Y., Zhou, Y., Chen, Y., Pan, K., Li, W., Zhou, X., Ma, W., Fu, C., et al. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201506225 · Cited by 397
Upconversion nanoparticles as versatile light nanotransducers for photoactivation applications
Idris, N. M., Jayakumar, M. K. G., Bansal, A., & Zhang, Y. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00158c · Cited by 385
Wang, T., Wang, D., Yu, H., Wang, M., Liu, J., Feng, B., Zhou, F., Yin, Q., Zhang, Z., Huang, Y., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b07706 · Cited by 295
Self-citationTuran, I. S., Yildiz, D., Turksoy, A., Gunaydin, G., & Akkaya, E. U. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201511345 · Cited by 274
Korbelik, M., Sun, J., & Cecic, I. (2005) · Cancer Research · doi:10.1158/0008-5472.1018.65.3 · Cited by 273
Yu, H., Zou, Y., Wang, Y., Huang, X., Huang, G., Sumer, B. D., Boothman, D. A., & Gao, J. (2011) · ACS Nano · doi:10.1021/nn203503h · Cited by 238
Self-citationPhotodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
Castano, A. P., Mroz, P., Wu, M. X., & Hamblin, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709256105 · Cited by 201
Self‐Assembled Fluorodendrimers Combine the Features of Lipid and Polymeric Vectors in Gene Delivery
Wang, H., Wang, Y., Wang, Y., Hu, J., Li, T., Liu, H., Zhang, Q., & Cheng, Y. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201501461 · Cited by 174
Targeting‐Triggered Porphysome Nanostructure Disruption for Activatable Photodynamic Therapy
Jin, C. S., Cui, L., Wang, F., Chen, J., & Zheng, G. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300651 · Cited by 164
Mcnutt, M. K. (2013) · Science · doi:10.1126/science.1249481 · Cited by 160
Bendz, H., Ruhland, S. C., Pandya, M. J., Hainzl, O., Riegelsberger, S., Bräuchle, C., Mayer, M. P., Büchner, J., Issels, R. D., & Noeßner, E. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704129200 · Cited by 130
Guo, C., Yu, H., Feng, B., Gao, W., Yan, M., Zhang, Z., Li, Y., & Liu, S. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.02.054 · Cited by 116
Self-citationKleinovink, J. W., van Driel, P. B., Snoeks, T. J. A., Prokopi, N., Fransen, M. F., Cruz, L. J., Mezzanotte, L., Chan, A. B., Löwik, C. W. G. M., & OSSENDORP, F. A. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0515 · Cited by 115
Gao, L., Zhang, C., Gao, D., Liu, H., Yu, X., Lai, J., Wang, F., Lin, J., & Liu, Z. (2016) · Theranostics · doi:10.7150/thno.14792 · Cited by 112
Ryter, S. W., & Gomer, C. J. (1993) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1993.tb04964.x · Cited by 80
Yu, H., Nie, Y., Dohmen, C., Li, Y., & Wagner, E. (2011) · Biomacromolecules · doi:10.1021/bm101464n · Cited by 72
Self-citationProgrammed Death‐1: Therapeutic Success after More than 100 Years of Cancer Immunotherapy
Dömling, A. S. S., & Holak, T. A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201307906 · Cited by 72
Kim, S., Heo, M. B., Hwang, G., Jung, Y., Choi, D. Y., Park, Y., & Lim, Y. T. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201501380 · Cited by 66
Dolina, J. S., Sung, S. J., Novobrantseva, T. I., Nguyen, T. M., & Hahn, Y. S. (2013) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2012.63 · Cited by 65
Muhanna, N., Cui, L., Chan, H. H. L., Burgess, L., Jin, C. S., MacDonald, T. D., Huynh, E., Wang, F., Chen, J., Irish, J. C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1235 · Cited by 63
Intracellular pH-activated PEG-b-PDPA wormlike micelles for hydrophobic drug delivery
Yu, H., Xu, Z., Wang, D., Chen, X., Zhang, Z., Yin, Q., & Li, Y. (2013) · Polymer Chemistry · doi:10.1039/c3py00849e · Cited by 61
Self-citationWang, D., Wang, T., Xu, Z., Yu, H., Feng, B., Zhang, J., Guo, C., Yin, Q., Zhang, Z., & Li, Y. (2015) · Small · doi:10.1002/smll.201502913 · Cited by 53
Self-citationMróz, P., Vatansever, F., Muchowicz, A., & Hamblin, M. R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-11-2572 · Cited by 43
Cited by
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Alsaab, H. O., Sau, S., Alzhrani, R., Tatiparti, K., Bhise, K., Kashaw, S. K., & Iyer, A. K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00561 · Cited by 1,707
Innovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
Li, X., Kwon, N., Guo, T., Liu, Z., & Yoon, J. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201805138 · Cited by 1,175
Nanoparticle‐Mediated Immunogenic Cell Death Enables and Potentiates Cancer Immunotherapy
Duan, X., Chan, C., & Lin, W. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201804882 · Cited by 1,033
Cancer nanomedicine for combination cancer immunotherapy
Nam, J., Son, S., Park, K. S., Zou, W., Shea, L. D., & Moon, J. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0108-1 · Cited by 940
Metadata
- Authors
- Wang, D., Wang, T., Liu, J., Yu, H., Jiao, S., Feng, B., Zhou, F., Fu, Y., Yin, Q., Zhang, P., Zhang, Z., Zhou, Z., & Li, Y.
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-08-17
- Volume
- 16
- Issue
- 9
- Pages
- 5503-5513
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2517071495
- Cited by
- 405
- References
- 43
- FWCI
- 23.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.